CLINICAL_TRIALS
trial_result
· 2016-10-28
Clinical Trial Update: A Study Of BRL49653C For The Treatment Of Type 2 Diabetes [Phase 3]
Summary
A Phase 3 clinical trial evaluating BRL49653C for type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED